... nodes in the infra or supraclavicular fossa or in the internal mammary chain was considered as a regional recurrence Any recurrence outside these areas was defined as DM Statistical Analysis LRR and ... DMe Alive DM Death DM Death DM Death DM Death DM Alive Out-come a Lateral, bMedial, cInvasive ductal carcinoma, dInvasive Paget’s disease, eDistance metastasis patients had lung metastasis and ... clear surgical margins (>1 mm) Axillary lymph node staging was performed in all patients Pathological staging was reviewed based on AJCC 2002 The date of evaluation was January 2009 Patient-related...
... supportive care [4,5] KRAS is an important molecule in the EGFR signaling pathway KRAS encodes a membrane-associated GTPase that is an early player in many signal transduction pathways KRAS acts as a molecular ... the intracellular domain is a catalytic site that has tyrosine kinase activity EGFR binds soluble ligands, including epidermal growth factors (EGFs) and transforming growth factor-alpha, and ... Schrama JG, Erdkamp FL, Vos A, Mol L, Antonini NF: Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2...
... with early stage cancers to receive combination therapy Examples for combination therapyinbreastcancer treatment are shown in Table 1.3 Early in the 1950’s, some encouraging results already ... plasma in patients Also, sodium valproate-pretreated rabbits showed an increase in midazolam brain levels, leading to an increase of the 50 midazolam response[152] Recently, ina pharmacokinetic ... inhibitor, has already undergone phase I clinical trials in patients with refractory metastatic cancer[ 121] and AIDSrelated Kaposi’s sarcoma[122] A random phase II trial reported that COL-3 administered...
... www-dep.iarc.fr/globocan/globocan.html] Jarvandi S, Montazeri A, Harirchi I and Kazemnejad A: Beliefs and behaviours of Iranian teachers toward early detection of breastcancer and breast self-examination ... operable breastcancer patients Eur J Cancer Prev 2001, 10:53-59 Ebrahimi M, Vahdaninia M and Montazeri A: Risk factors for breastcancerin Iran: a case-control study BreastCancer Research 2002, ... Iran social values and moral considerations limit the use of mass media for publicizing breastcancer awareness Breastcancer is not taboo but because the breast is regarded as part of female...
... participated in its design and coordination and helped to draft the manuscript All authors read and approved the final manuscript Competing interests The authors declare that they have no competing interests ... adenocarcinoma of the pancreas that developed extensive intratumoral calcification European Journal of Radiology Extra 2009, 71(2):e65-e69 Aydemir S, Savranlar A, Engin H, Cihan A, Ustundag Y, ... Malet A, Saigi E, Rey M: Gastrointestinal stromal tumors Abdom Imaging 2006, 31(4):387-399 Chamadol N, Laopaiboon V, Promsorn J, Bhudhisawasd V, Pagkhem A, Pairojkul C: Gastrointestinal stromal tumor:...
... Sydenham MA, Venables K, Yarnold JR: The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy 17 18 19 20 21 22 23 24 hypofractionation for treatment of early breast cancer: a ... concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility Tumori 2008, 94(5):706-11 Primary Therapy of Early Breast Cancer; 9th International ... 362:513-20 Guerrero M, Li XA, Earl MA, Sarfaraz M, Kiggundu E: Simultaneous integrated boost for breastcancer using IMRT: a radiobiological and treatment planning study Int J Radiat Oncol Biol Phys...
... postmastectomy breastcancer patients after radiation therapy Huang et al [25] has demonstrated that skin thickness measured via ultrasonic imaging proved to be a reliable quantitative and noninvasive measure ... 25:19-24 Paszat LF, Mackillop WJ, Groome PA: Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a populationbased study in Ontario, Canada Int J of Radiat ... postmenopausal breastcancer patients given adjuvant tamoxifen Danish BreastCancer Cooperative Group DBCG 82c randomised trial 1999, 353:1641-1648 Ragaz J, Jackson SM, Le N: Adjuvant radiotherapy and...
... expressed in normal human mammary epithelium and at a reduced level inbreastcancer cells leading to an alteration in the cell cycle, cell growth, and cell survival Materials and methods Human breast ... expressing both Per Figure cancer cell of PER Expression lines in human breast epithelial and breast Expression of PER in human breast epithelial and breastcancer cell lines Total cellular protein ... p53 can induce a transient arrest in G1 in cells, allowing cells time to repair damaged DNA [35] Activated p53 can also eliminate cells through mechanisms involving prolonged arrest in G1 and induction...
... Asia [1] For centuries, turmeric has been used as a spice and coloring agent in Indian food, as well as a therapeutic agent in traditional Indian medicine Enthusiasm for curcumin as an anti -cancer ... MiaPaCa 16 16 -ve FC NC NFκB κ MIAPaCa Figure 11 Nanocurcumin blocks activation of nuclear factor kappa B in pancreatic cancer cell lines Nanocurcumin blocks activation of nuclear factor kappa ... nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning Ann N Y Acad Sci 2004, 1030:434-441 Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal...
... swelling in his left breast He also had a significant family history for breastcancer including a maternal grandmother, two of his maternal aunts and a maternal first cousin diagnosed with breast ... Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas Am J Clin Pathol 2005, 123:36-44 Ganesan S, Karthik G, Joshi M, Damodaran ... Intracystic papillary carcinoma: a review of 917 cases Cancer 2008, 113:916-920 Dragoumis DM, Tsiftsoglou AP: Intracystic papillary carcinoma associated with ductal carcinoma in situ ina male breast...
... prognostic biomarkers Apart from breast cancer, the prognostic value of KLK5 expression has already been demonstrated for ovarian, bladder, prostate, colorectal and testicular cancerIn ovarian cancer, ... physical barriers and cells’ interaction, facilitating angiogenesis and cancer cells’ invasiveness and metastasis [2] Moreover, during the early stages of the disease, KLKs influence the availability ... expression inbreastcancer patients: a biomarker for the differential diagnosis of breast lesions Margaritis Avgeris1, Georgia Papachristopoulou1,2, Athanasios Polychronis2 and Andreas Scorilas1*...
... CATGGGAGAAAGATGTAGTCTGGGAGAC B CTCTTTCGGGACACAGCATCATAATC B CTCTTTCGGGACACAGCATCATAATC C GAAAGGACAGAGAAGGTGCCAGTTG B TTCGGGACACAGCATCATAA D ATCAAACTGGAGGGAGCAGA B TCAGACAGTGCCAGTGGAAG E GCCAGTGGAAGTGTAAGTTGG ... B TCGGGACACAGCATCATAA F GACACTGACAGGATTTACCATACTGTTGG B TCGGGACACAGCATCATAA G GGTCAAGTGTTCCCGTGATCCTACTG B TCGGGACACAGCATCATAA H CACAGGGAAATGCAGCACAGCTAG B AACCCCGTGTGTCCTTCAG I ACCGTCACTTTCCCTGTGTT ... GAACCTCGAGGCCCTGAATTGCCTTGATATCCAGCTCCCAGGAAC AP2γ in ERBS TCCGGGACAACGCGAACAGGGGCTCTGGAC AP1 in ERBS GCAGGTGAGACTGGCAAAGTTTGACCTGCTGCCGG AP4 in ERBS CTGAGTCAGACAAGCAACCGGGGCAGACGCAGGACAAGG FoxA1 in...
... discharge in patients over 50 years of age Clinical breast examination in primary care Each primary care team should include at least one practitioner who has had specific training in carrying ... supporting strategies for breastcancer patients D Measurement Structure • Availability of information incancer units about breastcancer and its treatment • • 30 Availability of training courses ... progress • Familial breast cancer: classification and care of women at risk of familial breastcancerin primary, secondary and tertiary care - clinical guideline (expected date of issue, Winter 2003)...
... of cases • Rate per 100,000 • World ASR* in the year NA NA NA NA Advanced breastcancer incidence* • Absolute number of cases • Rate per 100,000 • World ASR* in the year NA NA NA NA Breastcancer ... lessons learned in the European BreastCancer Network in which scientists, clinicians and paramedical staff as well as advocates, health care planners and administrators across Europe have shared ... ASSURANCE INBREASTCANCER SCREENING 1.1 Introduction That abreastcancer screening programme can reduce breastcancer mortality in the age group 40-74 years has been shown in several randomised...
... to Clinical Relevance Philipp Y Maximov and V Craig Jordan Chapter Targeted Apoptosis inBreastCancer Immunotherapy 23 Lin-Tao Jia and An-Gang Yang Chapter Induction of Apoptosis in Human Cancer ... Ali, Bassam Bitar, Farah T Logna, Main Y Maitah, Bin Bao, Shadan Ali, Dejuan Kong, Yiwei Li and Fazlul H Sarkar Chapter Multidrug Resistence and BreastCancer Gengyin Zhou and Xiaofang Zhang Chapter ... the adaptor molecule Fas-associated death domain (FADD) via interaction between their death domains (DD) FADD also contains a death effector domain (DED), which aggregates and activates another...
... (Amersham Pharmacia Biotech) were used for PCR: GPR30-forward, 5¢-AGTCGG ATGTGAGGTTCAG-3¢; GPR30-reverse, 5¢-TCTGTGT GAGGAGTGCAAG-3¢; TBP-forward, 5¢-TTTGGAAG AGCAACAAAGG-3¢; TBP-reverse, 5¢-AAGGGTGCAG ... the total RNA Statistical analysis Data for the correlation analysis were handled using a regression analysis of SSPI and/or a correlation analysis of EXCEL Data for the growth studies and immunochemistry ... proliferation was measured using BrdU and immunostaining (C) GPR30 upregulation (h) in different breastcancer cell lines correlated with growth (j) RNA was analysed by quantitative PCR using a LightCycler...
... not alter the localization of truncated BRCA1 or induce apoptosis ina cell line expressing mutated BRCA1 The data in Figs and suggest that TRAIL can alter BRCA1 localization and induce apoptosis ... as hypoxia A B induced changes in BRCA1 localization in malignant, but not in nonmalignant, mammary epithelial cells, we sought to determine whether TRAIL was involved in the localization change ... the involvement of a TRAIL-dependent process in mediating hypoxiainduced changes in BRCA1 localization TRAIL, but not hypoxia, induces apoptosis inbreastcancer cells As our data suggested that...
... detect breastcancer at a very early stage, as early detection increases survival rate Today, many cancers are detected late, when spreading to the surrounding tissue and metastases has taken place ... et al Translational research inbreastcancerA Fig IHC of nonmalignant epithelial cells (A) and tumour cells (B) from patient 46 using IL-6 antibodies (C) Haematoxylin and eosin staining of fat ... FEBS Translational research inbreastcancer Wnt ⁄ b-catenin signalling cascade [78–80] The latter plays an important role in development by augmenting the signalling activity of b-catenin, a structural...
... addition, breastcancer patients have been previously scanned using optical imaging; initial results indicate that this technique may supplement mammography and magnetic resonance imaging inbreastcancer ... crosstalk between adaptive and innate immune cells during breastcancer progression BreastCancer Res 2007, 9:212 Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation ... protein-1 in macrophage recruitment, angiogenesis, and survival in human breastcancer Clin Cancer Res 2000, 6:3282-3289 Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J: Integrin alpha4beta1 promotes...